ArticleThe EMBO journal2025
The INO80 chromatin remodeller facilitates DNA damage bypass via postreplicative gap repair.
Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- ATP-dependent chromatin remodelers in prostate cancer progression and therapeutic resistance.Endocrinology · 2026Review
- Epigenetic and chromatin remodeling mechanisms across cardiomyopathies: a comprehensive review.Epigenetics & chromatin · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Chromatin remodellers play a crucial role in transcription, replication and genome maintenance by dynamically regulating the accessibility of DNA. The INO80 complex contributes to multiple aspects of DNA repair and DNA replication stress management. It primarily facilitates nucleosome sliding and has been linked to the removal of the histone variant H2A.Z from chromatin. Our study demonstrates that the INO80 complex promotes DNA damage bypass through postreplicative daughter-strand gap repair. The complex acts downstream of PCNA ubiquitylation, enabling both Exo1-dependent gap expansion and gap filling via translesion synthesis or template switching. Importantly, its function in DNA damage bypass is independent of H2A.Z exchange and separable from its roles in DNA double-strand break repair and transcriptional regulation. Instead, it is consistent with a ruler-like activity that ensures proper nucleosome positioning around both ends of daughter-strand gaps, providing access to exonucleases and DNA polymerases involved in gap processing. These findings underscore the importance of the INO80 complex in facilitating access to damaged DNA regions for timely and effective repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.